Form 4: Nuvalent CDO Exercises Options, Sells Shares

Nuvalent's Chief Development Officer, Darlene Noci, exercised stock options and subsequently sold an equivalent number of Class A Common Stock shares.

Summary

• Darlene Noci, Nuvalent, Inc.'s Chief Development Officer, engaged in transactions involving Class A Common Stock on February 26, 2026.
• Noci acquired 5,500 shares of Class A Common Stock by exercising stock options at a price of $27.85 per share.
• Immediately following the option exercise, Noci sold a total of 5,500 shares of Class A Common Stock in multiple transactions.
• The sales occurred at weighted average prices of $102.64 (3,000 shares), $103.44 (2,300 shares), and $104.25 (200 shares).
• All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Noci on November 18, 2024.
• Following these transactions, Noci directly beneficially owns 58,117 shares of Class A Common Stock and 103,329 derivative securities (stock options).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transactions represent a routine exercise and sale by an insider under a pre-arranged 10b5-1 plan, which is a common practice for executive compensation and liquidity management, mitigating any negative signal from the sale.

Positives

• The option exercise price of $27.85 was significantly lower than the sale prices, indicating a profitable transaction for the insider.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned liquidity event rather than a reaction to new, negative information.

Negatives

• The sale of shares by a Chief Development Officer, even if pre-planned, can sometimes be perceived by the market as a lack of conviction, though the 10b5-1 plan mitigates this.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general market interpretation of insider selling.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for potential signals regarding management's confidence. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of a change in sentiment, as they are pre-scheduled and designed to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders may observe the insider sale, but the context of a Rule 10b5-1 plan typically reduces concerns about its implications for the company's immediate prospects.

Next Steps

• The remaining 103,329 stock options held by Darlene Noci will continue to vest over the four years following January 6, 2023, in equal monthly installments, subject to continued service to Nuvalent, Inc.

Key Dates

Recommendation

The transaction represents a routine exercise and sale by an insider under a pre-arranged 10b5-1 plan, which is a common practice for executive compensation and liquidity management. While it's an insider sale, the pre-planned nature reduces concerns about immediate negative sentiment regarding the company's prospects. It does not provide new fundamental information to warrant a change in investment thesis.

Keywords

Nuvalent, NUVL, Form 4, insider trading, stock options, share sale, Darlene Noci, Chief Development Officer, 10b5-1 plan